Correspondence Volume 122 | Issue 2 | February 2014
Iodine-131 and Thyroid Function
Global Health and Environmental Sciences, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA
Ostroumova et al. (2013) reported an association between iodine-131 (131I) dose and hypothyroidism in the Belarusian cohort, a cohort of individuals exposed to 131I from fallout of the Chernobyl accident when they were ≤ 18 years of age. Ostroumova et al. also examined other thyroid outcomes: hyperthyroidism, autoimmune thyroiditis, serum concentrations of thyroid-stimulating hormone, and autoantibodies to thyroperoxidase.
It may not be appropriate to include participants with other thyroid outcomes in the analysis because those thyroid outcomes could be indirectly associated with exposure. Chernobyl is in an iodine-deficient area (Ishigaki et al. 2001), and the prevalence of goiters among children ≤ 18 years of age has been reported at > 15% in this area (Hatch et al. 2011). Is high prevalence of goiters in the area caused by normal iodine deficiency or by the 131I? If the goiters were caused by 131I, the relationship between the 131I and hypothyroidism is still unclear, even though Ostroumova et al. (2013) stratified the data according to the presence of goiters. Hypothyroidism can also cause goiters (Wilkins et al. 1954); thus, goiter is just a serious hypothyroidism. That could be the explanation for the higher excess odds ratio in the group with goiter compared with the group without goiter shown in Table 3 of Ostroumova et al. (2013). It would have been better for Ostroumova et al. to perform a stratified analysis on the relationship between 131I and hypothyroidism based on the normal iodine level of the individual rather than the presence of goiter.
Ostroumova et al. (2013) also claimed that the thyroid radioactivity of individuals from the Belarus cohort was based on a previous study (Stezhko et al. 2004). However, Stezhko et al. (2004) did not provide the details of the individual radioactive iodine measurement. Were the original radioactive iodine measurements generated from a formula or modeled based on food intake or soil contamination, or was the 131I exposure level actually measured for each individual? The answer to this question is necessary because the two methods have different credibility. In addition, the exposure described by Stezhko et al. (2004) included 131I as well as other radioactive isotopes of iodine, not 131I alone. I would like to know whether Ostroumova et al. (2013) separated 131I from other radioactive iodine isotopes. Cesium-137 should also be considered as a potential confounder in the relationship between 131I and hypothyroidism.
Hatch M, Polyanskaya O, McConnell R, Gong Z, Drozdovitch V, Rozhko A, et al. 2011. Urinary iodine and goiter prevalence in Belarus: experience of the Belarus–American cohort study of thyroid cancer and other thyroid diseases following the Chornobyl nuclear accident. Thyroid 21:429–437.
Ostroumova E, Rozhko A, Hatch M, Furukawa K, Polyanskaya O, McConnell RJ, et al. 2013. Measures of thyroid function among Belarusian children and adolescents exposed to iodine-131 from the accident at the Chernobyl nuclear plant. Environ Health Perspect 121:865–871; doi: 10.1289/ehp.1205783.
Stezhko VA, Buglova EE, Danilova LI, Drozd VM, Krysenko NA, Lesnikova NR, et al. 2004. A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: objectives, design and methods. Radiat Res 161:481–492.
Wilkins L, Clayton GW, Berthrong M. 1954. Development of goiters in cretins without iodine deficiency: hypothyroidism due to apparent inability of the thyroid gland to synthesize hormone. Pediatrics 13:235–246.
EHP is pleased to present the abstracts from the 28th annual meeting of the International Society for Environmental Epidemiology (ISEE), held in Rome, Italy, 1–4 September 2016, and hosted by the Department of Epidemiology Lazio Regional Health Service, ASL Roma 1, and the Italian Epidemiological Association. The focus of this year’s conference is current and future challenges in exposure assessment, study design, and data analyses.
For a number of years, EHP has posted accepted manuscripts online as what we termed Advance Publications. The concept here was simple—to get the content online as quickly as possible in an effort both to get authors the attention they deserve and to get readers the information they need. This product has served our community well, but it is not without its flaws. … MORE
Featured Children’s Health
Birgit Claus Henn, Adrienne S. Ettinger, Marianne R. Hopkins, Rebecca Jim, Chitra Amarasiriwardena, David C. Christiani, Brent A. Coull, David C. Bellinger, and Robert O. Wright
Diane Gilbert-Diamond, Jennifer A. Emond, Emily R. Baker, Susan A. Korrick, and Margaret R. Karagas
Benjamin B. Green, Margaret R. Karagas, Tracy Punshon, Brian P. Jackson, David J. Robbins, E. Andres Houseman, and Carmen J. Marsit